Résultats de la recherche - 6 results
Human papillomavirus negative high grade cervical lesions and cancers: Suggested guidance for HPV testing quality assurance
Steffi; Søreng, Kristiane; Christiansen, Irene Kraus; Poljak, Mario; Lagheden, Camilla; Yilmaz, Emel; Eklund, Carina; Thapa, Hem R.; Querec, Troy D.; Unger, Elizabeth R.; Dillner, Joakim Source: Journal of ...
Can REALQUALITY RQ-HPV screen be considered as a clinically validated HPV test for use in cervical cancer screening?
Publication Type: Peer reviewed scientific article Authors: M. Arbyn; Cuschieri, Kate; Poljak, Mario; Bonde, Jesper Source: Clin Microbiol Infect, Volume 29, Issue 12 (2023) Keywords: Early ...
IPVS policy statement on HPV nucleic acid testing guidance for those utilising/considering HPV as primary precancer screening: Quality assurance and quality control issues.
Publication Type: Peer reviewed scientific article Authors: Garland, Suzanne M; Iftner, Thomas; Cuschieri, Kate; Kaufmann, Andreas M; M. Arbyn; de Sanjosé, Silvia; Poljak, Mario; Dillner, Joakim; ...
Clinical and analytical evaluation of the Alinity m HR HPV assay within the VALGENT-3 framework
Publication Type: Peer reviewed scientific article Authors: Sharon Dhillon; Valenčak, Anja Oštrbenk; Lan Xu; Poljak, Mario; M. Arbyn Source: Journal of Clinical Microbiology (2021) Abstract: Only ...
The European response to the WHO call cervical cancer as a public health problem
Publication Type: Peer reviewed scientific article Authors: M. Arbyn; Gultekin, Murat; Morice, Philippe; Nieminen, Pekka; Cruickshank, Maggie; Poortmans, Philip; Kelly, Daniel; Poljak, Mario; ...
Tackling cervical cancer in Europe amidst the COVID-19 pandemic.
Publication Type: Peer reviewed scientific article Authors: M. Arbyn; Bruni, Laia; Kelly, Daniel; Basu, Partha; Poljak, Mario; Gultekin, Murat; Bergeron, Christine; Ritchie, David; Weiderpass, ...